Literature DB >> 3315585

Acute coronary occlusion and reperfusion. Reliability of angiographic classification and grading.

S G Sorensen1, R A Hackworthy, P G Fitzpatrick, W H Barry, R L Menlove, J L Anderson.   

Abstract

93 patients with acute myocardial infarction entered into a multicentre, randomised fibrinolytic therapy study underwent coronary angiography prior to treatment with intracoronary streptokinase or intravenous anisoylated plasminogen streptokinase activator complex (APSAC). Subsequent to administration of fibrinolytic therapy, coronary arteriography of the infarct-related artery was also performed at 15, 30, 45, 60, 75 and 90 minutes. Angiographically defined coronary perfusion was graded as follows: grade 0--no perfusion; grade 1--vessel penetration by contrast without perfusion; grade 2--partial perfusion with delayed flow and/or clearance; grade 3--normal flow and clearance. Two independent readers at separate sites reviewed all serial angiograms with consensus achieved with a third reader. Disagreement potentially affecting therapeutic outcome (grades 1 vs 2, 0 vs 2, 0 vs 3, and 1 vs 3) occurred for only 15 angiographic views. Evaluation of agreement by the K index demonstrated a reasonable level of agreement for all grades (K = 0.73). In order to assess the effect of angiographic classification and timing upon reperfusion percentage rates, 4 reperfusion criteria were applied to these serial angiograms: group A = grade 2 or 3 flow at 90 minutes; group B = grade 2 or 3 flow at any time; group C = grade 1, 2 or 3 flow at any time in patients with control grade 0 or 1 flow; group D = grade 1, 2 or 3 flow at any time in patients with only grade 0 flow at control. Percentage reperfusion varied widely depending upon reperfusion criteria: group A: streptokinase 49%, APSAC 44%; group B: streptokinase 70%, APSAC 50%; group C: streptokinase 86%, APSAC 67%; group D: streptokinase 79%, APSAC 59%.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3315585     DOI: 10.2165/00003495-198700333-00027

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  26 in total

1.  Dose-dependent thrombolysis, pharmacokinetics and hemostatic effects of recombinant human tissue-type plasminogen activator for coronary thrombosis.

Authors:  H D Garabedian; H K Gold; R C Leinbach; T Yasuda; J A Johns; D Collen
Journal:  Am J Cardiol       Date:  1986-10-01       Impact factor: 2.778

2.  The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings.

Authors: 
Journal:  N Engl J Med       Date:  1985-04-04       Impact factor: 91.245

3.  Functional improvement of jeopardized myocardium following intracoronary streptokinase infusion in acute myocardial infarction.

Authors:  R S Stack; H R Phillips; D S Grierson; V S Behar; Y Kong; R H Peter; J L Swain; J C Greenfield
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

4.  Intravenous streptokinase in evolving acute myocardial infarction.

Authors:  W Ganz; I Geft; P K Shah; A S Lew; L Rodriguez; T Weiss; J Maddahi; D S Berman; Y Charuzi; H J Swan
Journal:  Am J Cardiol       Date:  1984-05-01       Impact factor: 2.778

5.  Early thrombolysis in acute myocardial infarction: limitation of infarct size and improved survival.

Authors:  M L Simoons; P W Serruys; M van den Brand; J Res; F W Verheugt; X H Krauss; W J Remme; F Bär; C de Zwaan; A van der Laarse
Journal:  J Am Coll Cardiol       Date:  1986-04       Impact factor: 24.094

6.  Long-term follow-up after intracoronary streptokinase for myocardial infarction: a randomized, controlled study.

Authors:  J L Anderson; P M McIlvaine; H W Marshall; B E Bray; F G Yanowitz; J R Lutz; R L Menlove; A D Hagan
Journal:  Am Heart J       Date:  1984-12       Impact factor: 4.749

7.  Prospective randomized trial of intravenous and intracoronary streptokinase in acute myocardial infarction.

Authors:  W J Rogers; J A Mantle; W P Hood; W A Baxley; P L Whitlow; R C Reeves; B Soto
Journal:  Circulation       Date:  1983-11       Impact factor: 29.690

8.  Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction.

Authors:  M A DeWood; J Spores; R Notske; L T Mouser; R Burroughs; M S Golden; H T Lang
Journal:  N Engl J Med       Date:  1980-10-16       Impact factor: 91.245

9.  A prospective trial of intravenous streptokinase in acute myocardial infarction (I.S.A.M.). Mortality, morbidity, and infarct size at 21 days.

Authors: 
Journal:  N Engl J Med       Date:  1986-06-05       Impact factor: 91.245

10.  Intracoronary thrombolysis in evolving myocardial infarction.

Authors:  W Ganz; N Buchbinder; H Marcus; A Mondkar; J Maddahi; Y Charuzi; L O'Connor; W Shell; M C Fishbein; R Kass; A Miyamoto; H J Swan
Journal:  Am Heart J       Date:  1981-01       Impact factor: 4.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.